Swire Pacific B (00087) spent 1.86 million Hong Kong dollars on repurchasing 187,500 shares on September 20th.
The announcement was made by TAIGU Holdings Company B (00087) on September 20, 2024, stating that the company had invested 186.08...
SWIRE PACIFIC B (00087) announced that the company has repurchased 187,500 shares at a total cost of HK$1.8608 million on September 20, 2024, with a repurchase price ranging from HK$9.76 to HK$9.97 per share.
Related Articles
As of May 28, 2026, S.F. Holding (06936) had repurchased a total of 154 million A-shares of the company.
Beijing Konruns Pharmaceutical (603590.SH): KC1036 will be presented in poster form at the 2026 ASCO meeting for the treatment of advanced thymoma.
Weichai Power (02338): Zhang Bo nominated as independent non-executive director.
As of May 28, 2026, S.F. Holding (06936) had repurchased a total of 154 million A-shares of the company.
Beijing Konruns Pharmaceutical (603590.SH): KC1036 will be presented in poster form at the 2026 ASCO meeting for the treatment of advanced thymoma.
Weichai Power (02338): Zhang Bo nominated as independent non-executive director.
